Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects
Clinical trial NCT00439010 · COMPLETED
Trial details
- NCT number
- NCT00439010
- Sponsor
- Molecular NeuroImaging
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.